59938-07-7Relevant articles and documents
TAU-PROTEIN TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
-
Paragraph 1156; 1157, (2021/02/12)
The present disclosure relates to bifunctional compounds, which find utility as modulators of tan protein. In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a VHL or cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds tan protein, such that tan protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of tan. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of tan protein. Diseases or disorders that result from aggregation or accumulation of tan protein are treated or prevented with compounds and compositions of the present disclosure.
Practical Synthesis of a Stable Precursor for Positron Emission Tomography Imaging Agent 18F-GTP1
Clagg, Kyle,Gosselin, Francis,Lim, Ngiap-Kie,Nack, William A.,O'Shea, Paul D.,Sirois, Lauren E.,White, Nicholas A.,Zhang, Haiming
, p. 1690 - 1699 (2020/11/25)
18F-GTP1 is a deuterated small molecule positron emission tomography (PET) imaging agent used to visualize tau tangles in Alzheimer's disease patients. The first-generation synthesis of 18F-GTP1's nonradiolabeled alkyl tosylate precursor was plagued by low-yielding steps, inefficient chromatographic purifications, and variable product quality. Due to these limitations, a more robust second-generation route was developed and successfully executed on kilogram scale. A reduction with LiAlD4 incorporated geminal deuterium atoms, while an efficient amidation reaction accessed the key acrylamide coupling partner. Moreover, the tricyclic imidazo[1,2-a]pyrimidine core was assembled via a novel, convergent, and highly selective phosphoramidate-directed annulation. The improved synthesis eliminated all chromatography en route to a high-yielding and reproducible acid-promoted tosylation as the final step.
Br?nsted Acid Catalyzed Tandem Defunctionalization of Biorenewable Ferulic acid and Derivates into Bio-Catechol
Bal, Mathias,Bomon, Jeroen,Liao, Yuhe,Maes, Bert U. W.,Sels, Bert F.,Sergeyev, Sergey,Van Den Broeck, Elias,Van Speybroeck, Veronique
supporting information, p. 3063 - 3068 (2020/02/05)
An efficient conversion of biorenewable ferulic acid into bio-catechol has been developed. The transformation comprises two consecutive defunctionalizations of the substrate, that is, C?O (demethylation) and C?C (de-2-carboxyvinylation) bond cleavage, occurring in one step. The process only requires heating of ferulic acid with HCl (or H2SO4) as catalyst in pressurized hot water (250 °C, 50 bar N2). The versatility is shown on a variety of other (biorenewable) substrates yielding up to 84 % di- (catechol, resorcinol, hydroquinone) and trihydroxybenzenes (pyrogallol, hydroxyquinol), in most cases just requiring simple extraction as work-up.
TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE
-
Paragraph 1440; 1441, (2018/05/24)
The present disclosure relates to bifunctional compounds, which find utility as modulators of tau protein. In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a VHL or cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds tau protein, such that tau protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of tau. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of tau protein. Diseases or disorders that result from aggregation or accumulation of tau protein are treated or prevented with compounds and compositions of the present disclosure.
Synthesis and RT inhibitory activity evaluation of new pyrimidine-based Seco-nucleosides
Vargas, Genaro,Escalona, Iker,Salas, Magali,Gordillo, Barbara,Sierra, Adolfo
, p. 243 - 257 (2007/10/03)
Eleven new 3 ′,4 ′- seco acyclic nucleosides (4-14) were prepared by nucleophilic substitution of protected pyrimidine bases on ethyl 3,3-diethoxypropanoate (3). Structures were characterized spectroscopically and a brief analysis of their conformation in solution was performed by the vicinal coupling constants 3 J H 2′ aH 3′ and 3 J H 2′ bH 3′. In solid state, compound 6 forms a homodimer linked by hydrogen bonding. In preliminary tests all compounds show low toxicity and gentle activity against HIV-1 RT in vitro. Copyright Taylor & Francis Group, LLC.
Trihaloacetylated enol ethers - General synthetic procedure and heterocyclic ring closure reactions with hydroxylamine
Colla,Martins,Clar,Krimmer,Fischer
, p. 483 - 486 (2007/10/02)
An improved procedure is described for preparing β-trichloro- and β-trifluoroacetyl derivatives of six simple enol ethers, in analytically pure form, high yield, and on an up to molar scale. The 4-alkoxy-1,1,1-trichloro[fluoro]-3-alken-2-ones 4a-c and 5a-c, thus obtained, are cyclocondensed with hydroxylamine hydrochloride (in pyridine, 35°C) to afford the 5-hydroxy-5-trichloro[fluoro]methyl-4,5-dihydroisoxazoles 6 and 7 in high yield. With cyclic substrates, i.e. the trihaloacetyl dihydrofurans and -2H-pyrans 4d, e and 5d, e, a competitive rearrangement reaction gives 3-cyano-2-hydroxy-2-trichloro[fluoro]methyltetrahydrofurans and -2H-pyrans 8 and 9, respectively. Direct condensation to a dihydroisoxazole prevails at 0°C (>85% for 4d, 5d), rearrangement to the cyano compounds at higher temperatures (65-70°C, > 70%). Under either condition, the respective heterocycle may be isolated in > 60% yield (except for 6e).
